BackSun Pharma Advanced Research Company Limited Overview

Sun Pharma Advanced Research Company Limited Current Cash

Track Sun Pharma Advanced Research Company Limited's current cash ($27M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$27.00M
↑ 187.23% YoYΔ $17.60M vs prior year quarter

Peer trimmed avg / median

Loading

Sun Pharma Advanced Research Company Limited Current Cash History

Loading

Sun Pharma Advanced Research Company Limited vs. peers: Current Cash Comparison

Loading

Sun Pharma Advanced Research Company Limited Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sun Pharma Advanced Research Company Limited (SPARC.NS) FAQ

Sun Pharma Advanced Research Company Limited's current cash stands at $27M as of September 2026. That compares with $9.4M in the prior-year period — up 187.2% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Sun Pharma Advanced Research Company Limited reported $27M in current cash versus $9.4M a year earlier — a 187.2% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $9.4M in the prior-year period — up 187.2% year over year. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Sun Pharma Advanced Research Company Limited's current cash evolved across reporting periods, while the comparison chart places SPARC.NS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.